Clinical Compound Library
Sizes available:
10 mM *30µl, 10 mM *50µl, 10 mM *100µl, 2*10 mM *100µl, 10 mM *250µl
Please contact us for price or customized libraries!
New drug development is a time-consuming and high-cost process. Drug repurposing (also called drug repositioning, reprofiling or re‑tasking) offers various advantages over developing an entirely new drug for a given indication, such as lower risk and less investment. Clinical drugs have confirmed bioactivities, clear mechanisms and high safety that are suitable for drug repurposing. MCE owns a unique collection of 2042 clinical compounds that refer to various research areas including anti-cancer, anti-infection, anti-inflammation, nervous disease. Those compounds are of detailed information on clinical development status, research area, targets, etc. MCE Clinical Compound Library can be supplied as pre-dissolved Solutions or Solid. For pre-dissolved solutions in this library, there are 1980 compounds supplied in 10 mM solution, 51 compounds supplied in 2 mM solution and 11 compounds supplied in 3 mg/mL solution. For pre-dissolved solutions, 10 mM for compounds with the solubility not lower than 10 mM, 2 mM for compounds with solubility between 2 mM and 10 mM, and 3 mg/mL for compounds with unconfirmed molecular weight and solubility not lower than 3 mg/mL.
Quantity | siehe Beschreibung |
---|---|
size | Get quote |
Storage and stability | -80°C |
Target | A useful tool for drug repurposing. |
Formulation | A collection of 2042 clinical compounds supplied as pre-dissolved Solutions or Solid Solution: 1980 compounds supplied in 10 mM solution, 51 compounds supplied in 2 mM solution, 11 compounds supplied in 3 mg/mL solution. |
Number of Compounds | 2042 (Modifications by manufacturer possible) |
Container | 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode |